SARS‐CoV protease inhibitors design using virtual screening method from natural products libraries

Two natural products databases, the marine natural products database (MNPD) and the traditional Chinese medicines database (TCMD), were used to find novel structures of potent SARS‐CoV protease inhibitors through virtual screening. Before the procedure, the databases were filtered by Lipinski's ROF and Xu's extension rules. The results were analyzed by statistic methods to eliminate the bias in target‐based database screening toward higher molecular weight compounds for enhancing the hit rate. Eighteen lead compounds were recommended by the screening procedure. They were useful for experimental scientists in prioritizing drug candidates and studying the interaction mechanism. The binding mechanism was also analyzed between the best screening compound and the SARS protein. © 2005 Wiley Periodicals, Inc. J Comput Chem 26: 484–490, 2005

[1]  G. Klebe,et al.  Statistical potentials and scoring functions applied to protein-ligand binding. , 2001, Current opinion in structural biology.

[2]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[3]  Ram Samudrala,et al.  Identifying inhibitors of the SARS coronavirus proteinase , 2003, Bioorganic & Medicinal Chemistry Letters.

[4]  J. Pezzuto,et al.  Biological activities of selected marine natural products. , 1994, Planta medica.

[5]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[6]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[7]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[8]  Zhihong Xu,et al.  Concept Design of Computer-Aided Study on Traditional Chinese Drugs , 1999, J. Chem. Inf. Comput. Sci..

[9]  I. Kuntz,et al.  Structure-Based Molecular Design , 1994 .

[10]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[11]  Jun Xu.  A new approach to finding natural chemical structure classes. , 2002, Journal of medicinal chemistry.

[12]  J. Tainer,et al.  Screening a peptidyl database for potential ligands to proteins with side‐chain flexibility , 1998, Proteins.

[13]  R M Knegtel,et al.  Efficacy and selectivity in flexible database docking , 1999, Proteins.

[14]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Jing Lei,et al.  A Marine Natural Product Database , 2002, J. Chem. Inf. Comput. Sci..

[16]  Luhua Lai,et al.  A New Atom-Additive Method for Calculating Partition Coefficients , 1997, J. Chem. Inf. Comput. Sci..

[17]  A. D. Groot,et al.  How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. , 2003 .

[18]  Hsuan-Cheng Huang,et al.  Small molecules targeting severe acute respiratory syndrome human coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Shoichet,et al.  Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. , 2002, Journal of medicinal chemistry.

[20]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[21]  Cheng Luo,et al.  A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. , 2003, Acta pharmacologica Sinica.

[22]  Alexander D. MacKerell,et al.  Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..

[23]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[24]  D. Faulkner.  Marine natural products (1999) , 2001 .

[25]  Kuo-Chen Chou,et al.  Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..

[26]  M Rarey,et al.  Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.

[27]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..